-
FDA Approves Gilead's Remdesivir For Treatment Of Hospitalized COVID-19 Patients
Thursday, October 22, 2020 - 3:42pm | 409Read More...The U.S. Food and Drug Administration has approved the antiviral Veklury, commonly known as remdesivir, for the treatment of hospitalized patients with COVID-19. What Happened: Gilead Sciences' (NASDAQ: GILD) remdesivir is approved for patients that are at least 12 years of age. The...
-
Ligand: The Small Cap Powering Gilead's Remdesivir
Monday, October 5, 2020 - 4:47pm | 946Read More...President Donald Trump has taken several treatments to combat the coronavirus diagnosis he received last week. Among them are an experimental antibody cocktail from Regeneron Pharmaceuticals (NASDAQ: REGN) and remdesivir, an antiviral treatment from Gilead Sciences (NASDAQ: GILD). About Remdesivir...
